Drug details

Utibron Neohaler (indacaterol and glycopyrrolate inhalation powder, for oral inhalation use)

type of

Utibron Neohaler (indacaterol and glycopyrrolate) inhalation powder is a combination of a long-acting beta2-adrenergic agonist (LABA) and an anticholinergic indicated for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).

The drug is often used to treat Chronic obstructive pulmonary disease .

This drug may have the following side effects:

• runny or stuffy nose,
• sore throat.
• back pain,
• high blood pressure (hypertension),
• mouth pain, and

The following drugs are related to Utibron Neohaler, either as a replacement or used together:

• Tudorza Pressair (aclidinium bromide)
• Advair Diskus (fluticasone propionate)
• Advair HFA (fluticasone propionate and salmeterol)
• Ventolin HFA (albuterol sulfate inhalation aerosol)
• Arcapta Neohaler (indacaterol inhalation powder)
• Brovana (arformoterol tartrate inhalation solution)
• Atrovent HFA (ipratropium bromide inhalation aerosol)
• Symbicort (budesonide and formoterol fumarate dihydrate)
• Combivent Respimat (ipratropium bromide and albuterol)
• Daliresp (roflumilast)
• Striverdi Respimat (olodaterol inhalation spray)
• Yupelri (revefenacin inhalation solution)
• Spiriva Respimat (tiotropium bromide inhalation spray)
• Stiolto Respimat (tiotropium bromide and olodaterol)